Old Web
English
Sign In
Acemap
>
authorDetail
>
Miki Inaba
Miki Inaba
Setsunan University
Immunology
FOXP3
Interleukin 10
Inflammation
Biology
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Sublingual immunotherapy for 4 years increased the number of Foxp3+ Treg cells, which correlated with clinical effects.
2021
Inflammation Research
Tetsuya Terada
Masaya Matsuda
Miki Inaba
Junpei Hamaguchi
Naoki Takemoto
Yusuke Kikuoka
Yuko Inaka
Harumi Sakae
Kennosuke Hashimoto
Hayato Shimora
Kazuyuki Kitatani
Ryo Kawata
Takeshi Nabe
Show All
Source
Cite
Save
Citations (0)
Type 1 regulatory T (Tr1) cells increased by sublingual immunotherapy (SLIT) suppressed allergic inflammation
2020
Masaya Matsuda
Tetsuya Terada
Miki Inaba
Junpei Hamaguchi
Naoki Takemoto
Kazuyuki Kitatani
Ryo Kawata
Takeshi Nabe
Show All
Source
Cite
Save
Citations (0)
Adoptive transfer of type 1 regulatory T cells suppressed the development of airway hyperresponsiveness in ovalbumin-induced airway inflammation model mice
2019
Journal of Pharmacological Sciences
Masaya Matsuda
Kana Doi
Tatsuya Tsutsumi
Miki Inaba
Junpei Hamaguchi
Tetsuya Terada
Ryo Kawata
Kazuyuki Kitatani
Takeshi Nabe
Show All
Source
Cite
Save
Citations (4)
Phenotype analyses of IL-10-producing Foxp3− CD4+ T cells increased by subcutaneous immunotherapy in allergic airway inflammation
2018
International Immunopharmacology
Masaya Matsuda
Yuki Morie
Hirotaka Oze
Kana Doi
Tatsuya Tsutsumi
Junpei Hamaguchi
Miki Inaba
Takeshi Nabe
Show All
Source
Cite
Save
Citations (7)
1